Avation Medical raises $22M for closed-loop wearable neuromod tech

The Vivally system. [Image courtesy of Avation Medical]Avation Medical announced today that it raised $22 million in a Series C financing round to support its wearable peripheral neuromodulation technology.

New investors ShangBay Capital and Asahi Kasei led the round. Other new investors included Angelini Ventures, JobsOhio Growth Capital Fund and more. Existing investors Arboretum Ventures, Tonkawa, Medtronic and Avestria Ventures participated, too.

Columbus, Ohio-based Avation plans to use funds to support the U.S. launch of its Vivally system.

Vivally, a non-invasive, FDA-cleared wearable neuromodulation system delivers closed-loop, autonomously adjusted electrical stimulation to treat patients with urge urinary incontinence (UUI) and urinary urgency caused by overactive bladder (OAB) syndrome. The system uses proprietary algorithms and electromyographic sensors.

Avation designed Vivally to detect and calibrate the level of energy delivered to the…

Read more
  • 0